Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 40

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 40
---
a similar broad range services in Asia Pacific at this time, current or future competitors may be successful in doing so in the future.
If current or future competitors are successful at developing a similar broad range of services, NewGenIvf’s financial performance
may be negatively impacted.

In addition, NewGenIvf believes
that there is growing awareness of the demand for fertility services. As the fertility services field gains more attention, more competitors
may be drawn into the market. NewGenIvf also could be adversely affected if NewGenIvf fails to identify or effectively respond to changes
in market dynamics. As a result of any of these factors, NewGenIvf may not be able to continue to compete successfully against its current
or future competitors, and this competition could result in the decrease in its clients base and market share and the failure of its
platform to continue to maintain market acceptance, which would materially and adversely affect its business, financial condition and
results of operations.

<div align='center'>25</div>

NewGenIvf has a limited operating history with its current platform of solutions, which makes it difficult to predict its future prospects, financial performance and results of operations.

The predecessor entity of
the Company prior to the Business Combination in April of 2024, NewGenIvf Limited, a Cayman Islands exempted company, was established
in 2019, and although its subsidiary First Fertility PGS Center Limited launched fertility services in 2014, has a limited operating
history. As a result of its limited operating history with its current platform of solutions, as well as a limited amount of time serving
a majority of its client base, its ability to accurately forecast its future results of operations, key operating data, net revenue,
cash flows, and operating margins is limited and subject to a number of uncertainties, including its ability to plan for and model future
growth. NewGenIvf’s historical revenue growth should not be considered indicative of its future performance. Further, in future
periods, its revenue growth could slow or decline for a number of reasons, including risks, challenges and uncertainties that NewGenIvf
has encountered and may continue to encounter that are frequently experienced by companies at an early stage, slowing demand for its
solutions and fertility services in general, changes in utilization trends by its clients, general economic slowdown, an increase in
unemployment, an increase in competition, changes to health care trends and regulations, changes to science relating to the fertility
market, a decrease in